⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China

Official Title: A Prospective, National, Multi-center, Non-intervention Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China

Study ID: NCT04830826

Interventions

Surgeries

Study Description

Brief Summary: This study is a prospective, national, multi-center, non-interventional study. The main purpose is to explore the initial adjuvant treatment pattern after radical resection for early-stage NSCLC patients with EGFR Mutation-Positive in the real world. The secondary purpose was to observe the postoperative follow-up treatment pattern and its subgroups (based on different EGFR mutation status and different clinical stages).

Detailed Description: About 2,000 eNSCLC patients who received radical resection from about 50 research centers across the country will be included in this study, and will be followed up to 2 years after enrollment according to the actual clinical situation. The analysis method of this study is mainly based on descriptive statistics. The information about the human genetic resources of the subjects to be collected includes: demography, physical examination, WHO fitness status, medical history, smoking history, disease characteristics, surgical information, initial and follow-up adjuvant treatment pattern, laboratory tests, survival status, and adverse events related to gefitinib/osimertinib, serious adverse events/non-severe ADR, measures taken for adverse events, outcome of adverse events.

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Beijing Cancer Hospital, Peking, Beijing, China

Beijing Chest Hospital,Capital Medical university, Peking, Beijing, China

Peking Union Medical College Hospital, Peking, Beijing, China

Peking University People'S Hospital, Peking, Beijing, China

Peking University Third Hospital, Peking, Beijing, China

Xuanwu Hospital Capital Medical University, Peking, Beijing, China

Chongqing Cancer Hospital, Chongqing, Chongqing, China

Fujian Provincial Hospital, Fuzhou, Fujian, China

Cancer Center of Guangzhou Medical university, Guangzhou, Guangdong, China

Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

The First Affiliated Hospital,Sun Yat-sen University, Guangzhou, Guangdong, China

Shenzhen People's Hospital, Shenzhen, Guangdong, China

Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China

The second affiliated hospital of guangxi medical university, Nanning, Guangxi, China

Cangzhou Central Hospital, Cangzhou, Hebei, China

The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

Anyang Tumour Hospital, Anyang, Henan, China

Henan Provincial People's Hospital, Zhengzhou, Henan, China

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

Xiangya Hospital Central South University, Changsha, Hunan, China

Jiangsu Province Hospital, Nanjing, Jiangsu, China

Suzhou Municipal Hospital, Suzhou, Jiangsu, China

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

The Second Affiliated Hospital Of Nanchang University, Nanchang, Jiangxi, China

Bethune first hospital of jilin university, Changchun, Jilin, China

China-Japan Union Hospital of JiLin University, Changchun, Jilin, China

The Second Hospital of Dalian Medical University, Dalian, Liaoning, China

Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

The First Hospital of China Medical University, Shenyang, Liaoning, China

Affiliated Hospital of Chifeng University, Chifeng, Neimenggu, China

The Affliated of Inner Mongolia Medical University, Hohhot, Neimenggu, China

Qilu Hospital of Shandong Yniversity, Jinan, Shandong, China

Shandong Cancer Hospital, Jinan, Shandong, China

PKUCare Luzhong Hospital, Zibo, Shangdong, China

Shanghai Jiaotong University Medical College Affiliated Ruijin hospital, Shanghai, Shanghai, China

Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China

ZhongShan Hospital, Shanghai, Shanghai, China

Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi, China

West China Hospital of Sichuan University, Chengdu, Sichuang, China

The Affliated of Southwest Medical University, Luzhou, Sichuang, China

Tianjin Chest Hospital, Tianjin, Tianjin, China

Tianjin Medical University General Hospital, Tianjin, Tianjin, China

Sir Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

The first affiliated hospital zhejiang university, Hangzhou, Zhejiang, China

The Second Affiliated hospital of Zhejiang University Achool of Medical, Hangzhou, Zhejiang, China

Zhejiang cancer hospital, Hangzhou, Zhejiang, China

Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China

Shaoxing People's Hospital, Shaoxing, Zhejiang, China

Taizhou Hospita of Zhejiang Province, Taizhou, Zhejiang, China

Contact Details

Name: jianxing He, President

Affiliation: The First Affiliated Hospital of Guangzhou Medical University

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: